September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
An Efficient fundus fluorescein angiography (FFA) Agent : Ag@Oxides Nanoprisms
Author Affiliations & Notes
  • Chuang Nie
    The 306th Hospital of PLA, Beijing, Beijing, China
  • Peng Du
    Changchun Institute of Optics Fine Mechanics and Physics Chinese Academy of Sciences, Changchun, China
  • hongwei zhao
    The 306th Hospital of PLA, Beijing, Beijing, China
  • xinshuai nan
    The 306th Hospital of PLA, Beijing, Beijing, China
  • Yuxin Li
    The 306th Hospital of PLA, Beijing, Beijing, China
  • Wenbin Wei
    Tongren Hospital, Beijing, China
  • Lianna Hu
    The 306th Hospital of PLA, Beijing, Beijing, China
  • Balamurali Ambati
    Moran Eye Center, University of Utah, Salt Lake City, Utah, United States
  • Zaicheng Sun
    Changchun Institute of Optics Fine Mechanics and Physics Chinese Academy of Sciences, Changchun, China
  • Ling Luo
    The 306th Hospital of PLA, Beijing, Beijing, China
  • Footnotes
    Commercial Relationships   Chuang Nie, None; Peng Du, None; hongwei zhao, None; xinshuai nan, None; Yuxin Li, None; Wenbin Wei, None; Lianna Hu, None; Balamurali Ambati, None; Zaicheng Sun, None; Ling Luo, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science September 2016, Vol.57, 1708. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Chuang Nie, Peng Du, hongwei zhao, xinshuai nan, Yuxin Li, Wenbin Wei, Lianna Hu, Balamurali Ambati, Zaicheng Sun, Ling Luo; An Efficient fundus fluorescein angiography (FFA) Agent : Ag@Oxides Nanoprisms
      . Invest. Ophthalmol. Vis. Sci. 2016;57(12):1708.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Nano-materials have been used widely applied for medical research because of its small size in recent years, however it is a virgin area in the field of ophthalmology. We created a new Silver-oxides core-shell nanoprisms (Ag@oxides NPs) -Fluorescein isothiocyanate (FITC) that be excited the fluorescence signal by 488nm. The purpose of this study was to demonstrate Ag @oxides nanoprisms can be used as a new effective agent in fundus fluorescein angiography (FFA).

Methods : Ag NPs were synthesized using a seed-mediated procedure. Ag@oxides NPs were prepared via a simple sol-gel route. The thickness of the oxides shell can be precisely tuned from 1 to 15 nm through changing the reaction time and amount of oxides sol-gel precursor. Cytotoxicity of Ag NP were tested in OCM-1 cells using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. OCM-1 cells were incubated with Ag@oxides NPs for 24 h and then imaged with the fluorescence microscope. Fundus of C57BL/6J mice were checked immediately by fluorescence fundus angiography after the tail vein injection of 0.3ml of Ag@oxides nanoprisms (100 μg mL-1).

Results : We developed a facile method to synthesize Ag@oxides core-shell NPs with a tunable shell thickness through the simple sol-gel route. Ag@oxides NPs exhibits a good biocompatiblity and stability due to the existence of oxide shell layer. MTT results showed that the cells were well tolerated to Ag@oxides NPs. The cells incubated with Ag@oxides NPs displayed quite intense green under laser excitation at wavelengths of 488 nm. The fundus fluorescein angiography (FFA) showed retinal vessels and capillary clearly and the fluorescence in retina lasted for 20 min at least.

Conclusions : Ag@oxides NPs might be used as a new agent for fundus fluorescein angiography.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×